| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |